Fig. 1

Comparison of glycated albumin levels between END and non-END groups according to stroke mechanisms. END = early neurological deterioration, LAA = large artery atherosclerosis, SVO = small vessel occlusion, CE = cardioembolism, OD = other determined, UD = undetermined. Among various mechanisms of stroke, statistically significant differences in glycated albumin levels were observed between the END and non-END groups only in stroke patients with LAA (P = 0.014) or SVO (P = 0.004) mechanisms. In stroke patients with CE, OD, and UD, glycated albumin levels did not show a statistically significant difference in the presence of END